We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$861M
AUM Growth
+$183M
Cap. Flow
+$184M
Cap. Flow %
21.37%
Top 10 Hldgs %
6.29%
Holding
1,670
New
726
Increased
225
Reduced
182
Closed
537

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$8.83M
2
COP icon
ConocoPhillips
COP
+$7.91M
3
VLO icon
Valero Energy
VLO
+$4.78M
4
TMUS icon
T-Mobile US
TMUS
+$4.39M
5
PSX icon
Phillips 66
PSX
+$4.38M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$18.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.37M
3
CSCO icon
Cisco
CSCO
+$4.36M
4
ADP icon
Automatic Data Processing
ADP
+$3.91M
5
COST icon
Costco
COST
+$3.83M

Sector Composition

Rank Sector Weight
1 Technology 14.13%
2 Industrials 13.43%
3 Consumer Discretionary 13.24%
4 Financials 13.11%
5 Healthcare 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA icon
1101
Ginkgo Bioworks
DNA
$487M
$50K 0.01%
+939
New +$59.5K
UGP icon
1102
Ultrapar
UGP
$6.71B
$48.4K 0.01%
+17,725
New +$44.8K
GBIO
1103
DELISTED
Generation Bio
GBIO
$46.6K 0.01%
+1,084
New +$52.4K
GRTS
1104
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$45.8K 0.01%
+16,459
New +$47K
HUMA icon
1105
Humacyte
HUMA
$182M
$45K 0.01%
+14,565
New +$41.4K
SKIL icon
1106
Skillsoft
SKIL
$58.9M
$44.7K 0.01%
+1,119
New +$40K
GRNA
1107
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$43.6K 0.01%
+100,820
New +$77.4K
ZH
1108
Zhihu
ZH
$279M
$42.3K ﹤0.01%
+5,552
New +$51.4K
OUST icon
1109
Ouster
OUST
$2.36B
$41.6K ﹤0.01%
4,969
-11,160
-69% -$129K
DC icon
1110
Dakota Gold
DC
$642M
$40.8K ﹤0.01%
+11,271
New +$37.3K
EGIO
1111
DELISTED
Edgio, Inc. Common Stock
EGIO
$39.7K ﹤0.01%
+1,254
New +$61.8K
VERU icon
1112
Veru
VERU
$36.6M
$38.7K ﹤0.01%
+3,338
New +$135K
MKFG
1113
DELISTED
Markforged Holding Corporation
MKFG
$38.4K ﹤0.01%
+4,010
New +$49.9K
OPTN
1114
DELISTED
OptiNose
OPTN
$36.7K ﹤0.01%
+1,269
New +$33.8K
QSI icon
1115
Quantum-Si Incorporated
QSI
$171M
$36.2K ﹤0.01%
+20,576
New +$40.6K
POWW icon
1116
Outdoor Holding Co
POWW
$250M
$36.1K ﹤0.01%
+18,336
New +$37.9K
WE
1117
DELISTED
WeWork Inc.
WE
$34.4K ﹤0.01%
+1,105
New +$60.4K
BVS icon
1118
Bioventus
BVS
$843M
$33.9K ﹤0.01%
+31,649
New +$60.5K
FXLV
1119
DELISTED
F45 Training Holdings Inc.
FXLV
$32.8K ﹤0.01%
+28,305
New +$67.3K
CTV
1120
DELISTED
Innovid Corp.
CTV
$32.6K ﹤0.01%
+23,119
New +$42.2K
YSG
1121
Yatsen Holding
YSG
$318M
$31.1K ﹤0.01%
+4,207
New +$31.6K
ALTO icon
1122
Alto Ingredients
ALTO
$349M
$28.2K ﹤0.01%
+18,810
New +$51.5K
MMAT
1123
DELISTED
Meta Materials Inc. Common Stock
MMAT
$27.7K ﹤0.01%
+679
New +$52.7K
PDYN icon
1124
Palladyne AI
PDYN
$244M
$27.1K ﹤0.01%
+9,529
New +$33.3K
CELU icon
1125
Celularity
CELU
$21.7M
$25.7K ﹤0.01%
+4,154
New +$33.4K

Similar funds

Y-Intercept (HK)'s Q1 2023 Portfolio in Review

As of Q1 2023, Y-Intercept (HK) held 1,670 positions worth $861M, up 27% from $678M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Y-Intercept (HK) deployed $184M of net new capital in Q1 2023, opening 726 new positions and adding to 225 existing holdings. Its largest new stake was Cigna: 30,314 shares worth $7.75M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $2.85M trimmed.

  • Y-Intercept (HK)'s largest Q1 2023 buy was Cigna: 30,314 shares worth $7.75M.
  • Y-Intercept (HK) added most to Valero Energy in Q1 2023, an estimated $4.78M increase.
  • Y-Intercept (HK)'s biggest Q1 2023 reduction was Applied Materials, cutting an estimated $2.85M.
  • Y-Intercept (HK) fully exited Apple in Q1 2023, selling an estimated $18.7M.
  • Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $861M portfolio in Q1 2023.
  • Y-Intercept (HK) opened 726 new positions and closed 537 in Q1 2023.
  • Y-Intercept (HK)'s portfolio value rose 27% quarter-over-quarter to $861M.

Based on Y-Intercept (HK)'s 13F filing for Q1 2023, filed 9 May 2023.